Last €17.38 EUR
Change Today -0.442 / -2.48%
Volume 0.0
5ZQ On Other Exchanges
As of 12:59 PM 10/20/14 All times are local (Market data is delayed by at least 15 minutes).

zeltiq aesthetics inc (5ZQ) Snapshot

Previous Close
Day High
Day Low
52 Week High
09/15/14 - €20.56
52 Week Low
10/29/13 - €6.58
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for ZELTIQ AESTHETICS INC (5ZQ)

zeltiq aesthetics inc (5ZQ) Related Bloomberg News

View More Bloomberg News

zeltiq aesthetics inc (5ZQ) Related Businessweek News

No Related Businessweek News Found

zeltiq aesthetics inc (5ZQ) Details

ZELTIQ Aesthetics, Inc., a medical technology company, is engaged in developing and commercializing non-invasive products for the selective reduction of fat. It offers CoolSculpting system, which utilizes proprietary controlled-cooling technology to selectively reduce stubborn fat bulges. The company sells its products through a network of distributors, as well as a direct sales force to dermatologists, plastic surgeons, and aesthetic specialists primarily in North America, the Asia-Pacific, Europe, the Middle East, Africa, and Latin America. The company was formerly known as Juniper Medical, Inc. and changed its name to ZELTIQ Aesthetics, Inc. in July 2007. ZELTIQ Aesthetics, Inc. was founded in 2005 and is headquartered in Pleasanton, California.

357 Employees
Last Reported Date: 07/29/14
Founded in 2005

zeltiq aesthetics inc (5ZQ) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $875.0K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $449.5K
Vice President of Operations
Total Annual Compensation: $219.1K
Senior Vice President, General Legal Counsel ...
Total Annual Compensation: $351.9K
Senior Vice President of Worldwide Sales and ...
Total Annual Compensation: $552.5K
Compensation as of Fiscal Year 2013.

zeltiq aesthetics inc (5ZQ) Key Developments

ZELTIQ Aesthetics, Inc. - Analyst/Investor Day

To discuss the company's long-term growth and profitability profile, additional marketing and expansion plans, R&D pipeline and include an interactive physician panel to discuss the CoolSculpting(R) technology and the market for non-invasive body contouring

ZELTIQ Aesthetics, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2014; Revises Earnings Guidance for the Full Year 2014

ZELTIQ Aesthetics, Inc. reported unaudited consolidated earnings results for the second quarter and six months ended June 30, 2014. For the quarter, the company reported revenues of USD 47,061,000 compared to USD 26,338,000 a year ago. Income from operations was USD 2,765,000 compared to loss from operations of USD 3,689,000 a year ago. Income before provision for income taxes was USD 2,696,000 compared to loss before provision for income taxes of USD 3,564,000 a year ago. Net income was USD 2,769,000 or USD 0.07 per basic and diluted share compared to net loss of USD 3,607,000 or USD 0.10 per basic and diluted share a year ago. Adjusted EBITDA was USD 5,647,000 compared to adjusted LBITDA of USD 1,787,000 a year ago. The second quarter success was driven by increasing CoolSculpting(R) momentum and awareness and can also be attributed to the sales and marketing investments the company made in the first quarter, a strong trade show presence and robust customer adoption of newest applicator, CoolSmooth(TM). For the six months, the company reported revenues of USD 78,036,000 compared to USD 46,320,000 a year ago. Loss from operations was USD 4,446,000 compared to USD 11,154,000 a year ago. Loss before provision for income taxes was USD 4,562,000 compared to USD 11,039,000 a year ago. Net loss was USD 4,568,000 or USD 0. 12 per basic and diluted share compared to USD 11,089,000 or USD 0.31 per basic and diluted share a year ago. Net cash used in operating activities was USD 10,331,000 compared to USD 6,236,000 a year ago. Purchase of property and equipment was USD 770,000 compared to USD 306,000 a year ago. Adjusted EBITDA was USD 997,000 compared to USD 7,705,000 a year ago. The company revised earnings guidance for the full year 2014. The company remains excited about the potential in 2014 and increased confidence has led the company to significantly raise full year 2014 revenue guidance to USD 160 million to USD 165 million, or 43% to 48% year-over-year growth, up from prior guidance of USD 137 million to USD 140 million and to guide to a full year positive adjusted EBITDA margin. Gross profit margin of approximately 70%; unchanged from prior guidance.

ZELTIQ Aesthetics, Inc., Q2 2014 Earnings Call, Jul 29, 2014

ZELTIQ Aesthetics, Inc., Q2 2014 Earnings Call, Jul 29, 2014


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
5ZQ:GR €17.38 EUR -0.442

5ZQ Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Cutera Inc $9.98 USD -0.10
El.En. SpA €20.60 EUR -0.09
Lutronic Corp 23,850 KRW +900.00
PhotoMedex Inc $4.69 USD -0.22
Syneron Medical Ltd $8.92 USD +0.05
View Industry Companies

Industry Analysis


Industry Average

Valuation 5ZQ Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 5.8x
Price/Book 13.6x
Price/Cash Flow NM Not Meaningful
TEV/Sales 5.5x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ZELTIQ AESTHETICS INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at